Cargando…
Biomaterial-based platforms for in situ dendritic cell programming and their use in antitumor immunotherapy
Dendritic cells (DCs) are central players in the immune system, with an exquisite capacity to initiate and modulate immune responses. These functional characteristics have led to intense research on the development of DC-based immunotherapies, particularly for oncologic diseases. During recent decad...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727507/ https://www.ncbi.nlm.nih.gov/pubmed/31484548 http://dx.doi.org/10.1186/s40425-019-0716-8 |